CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 386 enrolled
Drug / intervention
PERIPHERAL NERVE BLOCKother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05635383
NCT05635383N/ACompleted

Investigation of the Frequency and Causes of Rebound Pain Phenomenon After Peripheral Nerve Blocks

Diskapi Yildirim Beyazit Education and Research Hospital·observational·Posted Dec 2, 2022·Updated Mar 28, 2024

In Brief

An observational study evaluating PERIPHERAL NERVE BLOCK for Pain and Block. Completed, enrolled 386 participants across 2 sites.

Detailed Summary

In recent years, the use of regional anesthesia techniques as part of multimodal analgesia strategies to maximize pain control in patients has reduced opioid requirements and promoted early mobility and rehabilitation in the perioperative period. Regional anesthesia has benefits, mainly peripheral nerve blocks (PNB), muscle relaxation, and postoperative analgesia, thus allowing for control of postoperative pain and early discharge from the hospital. In addition, using PNB techniques provides: Hemodynamic stability. Reduced need for a post-anesthetic care unit (PACU). Reduced unplanned hospitalization for pain control. Less airway management. Reduced incidence of opioid-related adverse events. Greater patient satisfaction The main feature of rebound pain is that it is severe pain, within 8-24 hours after PNB. It usually remains severe for 2-6 hours, but the subsequent pain trajectory is consistent with the recovery process expected at surgical intervention. Therefore, rebound pain is temporary and different from persistent post-surgical pain (PPSP). Rebound pain often occurs at night. However, this is probably related to the 8 to 12-hour duration of most single-injection PNBs and the completion of most elective surgeries during daylight hours.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Block
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedDec 2, 2022
Enrollment StartAug 1, 2022
Primary CompletionJan 1, 2024
Study CompletionMar 12, 2024
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 3.6 years ago

Interventions

PERIPHERAL NERVE BLOCKother

Observation of rebound pain after peripheral nerve block application